Morgan Stanley Fulcrum Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 350,685 shares of FULC stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

350,685

Previous 1,234,813 71.6%

Holding current value

$1.6 Million

Previous $7.66 Million 83.66%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.18 - $9.74 $2.81 Million - $8.61 Million	-884,128 Reduced 71.6%	350,685 $1.25 Million
Q2 2024 Oct 17, 2024	BUY	$5.98 - $9.31 $464,502 - $723,163	77,676 Added 6.71%	1,234,813 $7.66 Million
Q2 2024 Aug 14, 2024	BUY	$5.98 - $9.31 $464,502 - $723,163	77,676 Added 6.71%	1,234,813 $7.66 Million
Q1 2024 Oct 17, 2024	SELL	$6.7 - $12.0 $520,429 - $932,112	-77,676 Reduced 6.29%	1,157,137 $10.9 Million
Q1 2024 Aug 16, 2024	SELL	$6.7 - $12.0 $414,877 - $743,064	-61,922 Reduced 5.08%	1,157,137 $10.9 Million
Q1 2024 May 15, 2024	SELL	$6.7 - $12.0 $414,877 - $743,064	-61,922 Reduced 5.08%	1,157,137 $10.9 Million
Q4 2023 Aug 16, 2024	SELL	$3.18 - $6.86 $50,097 - $108,072	-15,754 Reduced 1.28%	1,219,059 $8.23 Million
Q4 2023 Feb 13, 2024	BUY	$3.18 - $6.86 $976,857 - $2.11 Million	307,188 Added 33.69%	1,219,059 $8.23 Million
Q3 2023 Nov 15, 2023	SELL	$3.25 - $6.08 $624,009 - $1.17 Million	-192,003 Reduced 17.39%	911,871 $4.05 Million
Q2 2023 Aug 14, 2023	SELL	$2.26 - $3.8 $132,196 - $222,277	-58,494 Reduced 5.03%	1,103,874 $3.64 Million
Q1 2023 May 15, 2023	SELL	$2.83 - $13.99 $31,817 - $157,289	-11,243 Reduced 0.96%	1,162,368 $3.31 Million
Q4 2022 Feb 14, 2023	SELL	$5.01 - $8.35 $133,721 - $222,869	-26,691 Reduced 2.22%	1,173,611 $8.54 Million
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $105,022 - $194,248	21,346 Added 1.81%	1,200,302 $9.71 Million
Q2 2022 Oct 27, 2022	BUY	$4.2 - $24.0 $296,234 - $1.69 Million	70,532 Added 6.36%	1,178,956 $5.78 Million
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $296,234 - $1.69 Million	70,532 Added 6.36%	1,178,956 $5.78 Million
Q1 2022 Oct 27, 2022	SELL	$9.96 - $23.65 $702,498 - $1.67 Million	-70,532 Reduced 5.98%	1,108,424 $26.2 Million
Q1 2022 May 13, 2022	BUY	$9.96 - $23.65 $10.1 Million - $24.1 Million	1,018,874 Added 1137.77%	1,108,424 $26.2 Million
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $63,546 - $129,089	4,539 Added 5.34%	89,550 $1.58 Million
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $618,880 - $2.63 Million	85,011 New	85,011 $2.4 Million

Others Institutions Holding FULC

# of Institutions

150

Shares Held

52.2M

Call Options Held

6.91M

Put Options Held

1.9M

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account